Introduction
Accidental awareness during general anaesthesia (AAGA) can be described as unintentional consciousness during a procedure in which general anaesthesia is intended. The Michigan awareness classification instrument [1] describes levels of awareness ranging from no awareness through broken auditory perceptions to awareness of paralysis and pain. Such awareness may be unpleasant, and can lead to long-term psychological effects [2] [3] [4] . Through the Brice protocol [5] , or a derivative of it, many studies, both randomised, controlled trials (RCT) and observational studies, have found that possible or definite awareness occurred in one to two cases per 1000 general anaesthetics [6] [7] [8] [9] [10] [11] [12] . However, other methodologies have identified a considerably lower rate of AAGA [13] [14] [15] . Bispectral index (BIS) monitoring of the frontal electroencephalogram (EEG) has been investigated as a possible method for limiting AAGA [7] [8] [9] 16] . Although BIS usage has demonstrated mixed results [15, 17] , BIS monitors (and other EEG-based monitors) are still included in UK guidelines for some anaesthetic settings [18, 19] . Risk factors for accidental awareness, then, are not fully understood, but are known to be linked with an (unintentional or intentional) inadequate dose of an anaesthetic agent and inadequate monitoring of neuromuscular blockade [14] . These are not easily explored, however, as studying uncommon events using RCTs or less rigorous study designs can present problems of statistical power and confounding variables.
Nitrous oxide gas is a weak anaesthetic agent, but is commonly used with oxygen and other agents such as a volatile anaesthetic agent for the maintenance of anaesthesia [20] . The challenges of investigating effects from sparse data affect not only trials but also reviews seeking to synthesise these rare events [21] . The present review was conceived partly in response to a 1996 review by Tramer et al., which suggested that there may be a potential increase in the risk of AAGA associated with a nitrous oxidefree anaesthetic [22] . Nitrous oxide has been linked by some other studies and authors with a potential decreased risk of AAGA [23, 24] , whereas other studies have reported the opposite [25, 26] . Nitrous oxide differs from other conventional anaesthetic agents in that, in terms of molecular targets, it is considered primarily a N-methyl-D-aspartate (NMDA) antagonist as opposed to a gamma-aminobutyric acid (GABA) agonist [27] , but exactly why nitrous oxide might affect the risk of AAGA is not known. It has been suggested that nitrous oxide might decrease the risk of AAGA because it is a more powerful memory suppressant than equivalent agents [28] , or because of more rapid pharmacokinetics, which enables clinicians to better predict the dose received by the patient [29] .
Alternatively, there may be antagonism between anaesthetic agents which act on GABA receptors and the antinociceptive effects of nitrous oxide, which may increase the risk of awareness [30, 31] . At present, we do not know whether nitrous oxide affects AAGA due to a direct action on the brain, alters the action of other anaesthetic agents to affect AAGA or has no effect on AAGA. The use of brain activity monitors in patients anaesthetised using nitrous oxide is complex, since NMDA antagonists suppress cortical EEG less than GABA-ergic agents and it has been shown that BIS values do not change during nitrous oxide sedation [32] . Using brain monitors to titrate nitrous oxide-based anaesthesia may therefore lead to an increase in dose and inappropriately deep anaesthesia [27] .
In a 2015 national survey, nitrous oxide was noted to be used in 29% of all general anaesthetics (i.e. approximately 770,000 cases out of 3 million total cases per year in the UK), including in 45% of paediatric cases and 71% of general anaesthetic for caesarean section [20] . There has been recent concern about the possible adverse consequences, such as increases in cardiovascular complications, wound infection and nausea and vomiting, of using nitrous oxide as an anaesthetic agent [33] . The ENIGMA-2 trial found that use of nitrous oxide in a volatile-based anaesthetic had no impact on cardiovascular complications or wound infection, but confirmed increased nausea and vomiting [34] . The primary objective of this review was to assess the effect of the inclusion of nitrous oxide, as part of a general anaesthetic, on the risk of AAGA in patients aged five years and older undergoing a surgical procedure.
Methods
A protocol [35] for conducting this systematic review and the full published review [36] are available elsewhere. We considered all RCTs including quasi-randomised studies and cluster-randomised studies. We included trials of participants aged five years or older, receiving general anaesthesia for any type of surgery. Only studies that included a prospective method for detecting (and reporting) AAGA were included.
We included trials in which participants receiving general anaesthesia that included nitrous oxide for maintenance at a concentration of ≥ 30% were compared with participants receiving no nitrous oxide. The intervention group must have received nitrous oxide in conjunction with an additional anaesthetic. An additional anaesthetic could have been an inhalation anaesthetic (such as sevoflurane, enflurane or isoflurane), or an intravenous (i.v.) anaesthetic (such as propofol). We included studies in which the additional anaesthetic agent for the intervention and comparison group was at the discretion of the anaesthetist as differences between groups in the anaesthetic delivery would be accounted for by randomisation. We excluded studies where participants were randomised to different anaesthetic techniques apart from the administration of nitrous oxide, for example, inhalation vs. i.v. anaesthetic.
We assumed that all minimum alveolar concentrations (MAC) of different agents, including nitrous oxide, were considered additive. We used this assumption and the MAC values to determine the equivalence of anaesthetic depth between studies, and to exclude studies if the study groups were maintained at different depths. Assessment of equality of depth in the study using total intravenous anaesthesia (TIVA) was judged by two experienced clinical authors (TC, AS). We had intended to conduct a sub-group analysis of studies which used specified additional anaesthetic agents, such as propofol, as part of an established protocol, but there were insufficient studies to do so.
The primary outcome was explicit AAGA. Precise definitions for AAGA vary [10, 37] , so for studies which divide awareness in this way, we included probable and definite awareness events only. We included only the events which were described to have taken place during anaesthesia. We included studies which used the Brice protocol [5] or those with other direct questioning methods, including over a shorter period. Unlike Tramer et al., we only included studies in which AAGA was reported as a pre-defined outcome, to limit reporting bias. There were no secondary outcomes.
We searched the following electronic databases: Cochrane Central Register of Controlled Trials (CEN-TRAL), MEDLINE (Ovid) and Embase (Ovid). We applied the Cochrane highly sensitive filter for RCTs in MEDLINE and Embase [38] . The search strategy used for MEDLINE can be found in the published protocol [35] . We also searched the following trial registers: www.clinicaltrials.gov, the WHO International Clinical Trials Registry Platform (www.who.int/ictrp/ne twork/en/) and Current Controlled Trials (www.isrc tn.com/). We also conducted forward citation searches on Tramer et al.'s review article [22] , and backwards citation searches on two studies [22, 39] using the Scopus and Web of Science databases. The searches were performed on 9 December 2015. There were no language restrictions.
Two out of three authors screened all titles and abstracts to remove studies that were very unlikely to be eligible. We piloted 100 titles before reviewing all titles in order to clarify criteria for discarding articles at this stage. If no abstract was available but the title was possibly relevant, we obtained the full text of the article. When we had screened all titles and abstracts, two of the same three authors reviewed the full texts of potentially relevant titles. Any differences which could not be resolved were referred to an additional author. This process is summarised in Fig. 1 . All extracted data were then transferred into Review Manager software [40] .
Two authors used the Cochrane risk of bias tool to independently assess the following: random sequence generation; allocation concealment; blinding of participants and personnel (performance bias); blinding of outcome assessors (detection bias); incomplete outcome data; other sources of bias. Studies were judged to be at a high risk of attrition bias in the incomplete outcome data domain if they had a participant attrition rate of > 20%.
The single outcome in this review is dichotomous (occurrence of AAGA). For the benefit of analytic utility we planned to divide outcome data into three groups based on separate time-points: (1) all data for AAGA irrespective of assessment time-point; (2) studies which assessed AAGA in recovery; (3) studies which assessed AAGA 24 h postoperatively. We used the calculator in Review Manager software [40] to calculate odds ratios (OR) with 95% confidence intervals (CI). We used Peto ORs as AAGA is a rare event and we anticipated that event data would be sparse.
Results
We retrieved 8976 records from the electronic databases and 226 from citation and trial searches. After duplicates were removed, we screened 4539 records for inclusion. Of these, we selected 225 for full-text review, of which 188 papers were excluded because they did not meet our eligibility criteria. After this process we identified a further 15 papers, reporting on 12 studies [34, [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] , which also required exclusion for not meeting these criteria. Of these 12 studies, six did not include an intervention or comparator relevant to this review [42, 43, [47] [48] [49] 51] , in five studies the depth of anaesthesia differed between study arms [41, [44] [45] [46] 50] and two papers reported on the ENIGMA-2 study [34, 52] , which did not measure AAGA. Through this process we identified 22 publications covering 15 RCTs for inclusion in the review [33, [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] .
One study [61] , although included in the qualitative synthesis of this review, could not be included in the primary analysis as the number of participants in each group was not reported. Eleven studies included a single comparison of a study group with nitrous oxide and a group without nitrous oxide [33, 55, 56, [58] [59] [60] [61] [62] [64] [65] [66] , whereas four studies included more than one comparison [53, 54, 57, 63] . These 'multi-arm' studies, included four [53, 54, 57] or three [63] comparison groups. The anaesthetic agents used in the studies varied, with seven using propofol [55, 56, [59] [60] [61] [62] 65] , three using sevoflurane [53, 54, 63] , three using isoflurane [53, 58, 64] and two using desflurane [57, 66] . One study left additional anaesthetic agents to the discretion of the anaesthetists [33] . Concentrations of nitrous oxide used in the included studies also varied, with two studies using 50% [60, 63] , four studies 60% [54, 57, 58, 64] , one study 65% Figure 1 Flow chart of search method and study selection.
[55], one study 66% [61] , two studies 67% [59, 66] ) and five studies 70% [33, 56, 62, 63, 65] . The methods used by anaesthetists to monitor depth of anaesthesia varied considerably. Eight studies used clinical signs/haemodynamic changes [33, 55, 56, 58, 59, 62, 65, 66] , four studies delivered fixed concentrations [54, 57, 60, 63] and two studies used clinical experience but with no criteria stated [61, 64] . Three studies used EEG-based monitoring; one as the sole monitor of anaesthetic depth [53] , two in addition to other forms of monitoring [33, 58] .
None of the included studies had AAGA as a primary outcome, and the methods of AAGA ascertainment varied across the studies. One study [33] used the Brice protocol [5] , and two studies used a modified version of the Brice protocol [53, 64] . A further two studies used a different structured questionnaire [58, 59] . All other studies questioned participants more informally. The timing of assessment also varied, with seven studies assessing AAGA while participants were in recovery [55, 56, 58, 60, 61, 65, 66] and in 10 studies 24 h postoperatively [33, 53-55, 57-59, 61, 63, 64] . One study [62] not only reported that AAGA was assessed at discharge but also reported that data were collected 2 h after anaesthesia.
The risk of bias within and across studies varied considerably ( Table 1) . Methods of random sequence generation were generally poorly reported among studies, with six studies failing to provide sufficient detail. Nine studies provided adequate information on randomisation methods and we judged these to have a low risk of bias across studies. Eleven studies did not provide sufficient information regarding efforts to conceal group allocation. For reasons of patient safety, the anaesthetist could not be blinded to the intervention; therefore, we judged all studies to be at a high risk of performance bias. We judged seven studies to be at a low risk of detection bias; authors of these studies reported that investigators and/or participants were blinded to group allocation. No studies reported a complete absence of blinding. Eight studies reported no participant attrition during the study period. One study reported significant (59%) participant attrition, and was marked as high risk. As pre-specified accidental awareness outcome was part of the inclusion criteria for this review, we were not concerned by risk of selective reporting bias. We did not identify any other sources of bias across the studies.
Of the 15 RCTs, 14 were included in the primary analysis. Four studies [53, 54, 57, 63] included more than one comparison and are therefore included in the analysis for each comparison. Due to lack of sufficient data and imprecise reporting, it was not possible to adequately subdivide the events by time-points as intended. A total of three AAGA events were reported in the 14 analysed studies (3439 participants). All three events were reported by patients who received nitrous oxide-based anaesthesia. There were two events in the ENIGMA study [33] . We could not determine from the published paper when AAGA was assessed, that is, in recovery or at 24 h postoperatively. The third event, in Arellano 2000 [55] , was reported by the study authors to be the result of a technical failure in the anaesthesia process (a kink in the propofol i.v. line) rather than a result of the pharmacological intervention. This assessment took place after anaesthesia, but there was no specific time-point recorded. Given the very small number of events from a similarly small number of studies, we judged that it was not appropriate to pool data or conduct a meta-analysis for this outcome. Using the GRADE approach principles [67] , we downgraded the quality of the evidence by one level (poor), due to concerns about the risk of bias, and by two levels (very poor) due to concerns around imprecision ( Table 2) .
Discussion
We included 15 RCTs, of which 14 were included in the primary analysis. In these studies 3439 participants were randomised to receive anaesthetic agents including nitrous oxide, as part of a general anaesthetic. A total of three AAGA events were reported in two studies [33, 55] . We considered pooling of data through meta-analyses and sub-groups to be inappropriate given this paucity of data. It is therefore not possible to draw any direct conclusions about the primary outcomes. What we must conclude, then, is that the question of the risk of AAGA with or without nitrous oxide is left unanswered. None of the included trials were designed to measure AAGA as a primary outcome, and all were underpowered to study this outcome. We judged the evidence relating to the impact of use of nitrous oxide on the risk of AAGA to be of very low quality.
As our review failed to find sufficient evidence to draw any outcome-related conclusions, it is not possible for us to confirm or contest any findings from Results not pooled due to rarity of events Not pooled Not pooled *The risk in the intervention group (and its 95%CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95%CI). 1 The anaesthetist delivering the anaesthetic was aware of the allocation in all studies, as this is essential for patient safety, so we rated all studies at high risk of performance bias and downgraded one level for study limitations. We downgraded two levels for imprecision because of rarity of events in few studies.
other reviews or studies. We cannot determine whether the use of nitrous oxide in general anaesthesia increases, decreases or has no effect on the risk of AAGA. The review and meta-analysis by Tramer et al. in 1996 , which hitherto is the only known review to directly address the association between nitrous oxide usage and incidence of AAGA, reported that there was an increased risk in patients who did not receive nitrous oxide [22] . The data in this 1996 review, however, are less than reliable considering that the review was designed to investigate the association between nitrous oxide and nausea/vomiting, meaning that there was no discrimination of studies according to whether AAGA was prospectively defined or sought [22] . Illustrative of this, two studies included in the Tramer review which reported incidents of AAGA in the nitrous oxide-free group [68, 69] were not included in this review because the study authors did not prespecify that AAGA data were to be collected. Although some, more narrative, reviews have incorporated the findings of the Tramer review, the recent 5th National Audit Project (NAP5) observational study did not find an association between nitrous oxide and accidental awareness [13, 14] . This important study relied on spontaneous self-reporting, but it was prospective and was designed to identify awareness. One important limitation of our review is that we based the review on the assumption that the effects of nitrous oxide and other agents are additive. Recently, and since we conducted our review, other research has explored the possibility of infra-additivity (antagonism) of nitrous oxide and other agents, particularly sevoflurane [31, 70] . If this hypothesis is indeed correct it could be that some of the studies we excluded because the anaesthetic depth in the two groups was not equivalent could be usefully included. However, reviewing the five studies that were excluded because anaesthetic depth (based on the simple sum of MACs of anaesthetic agents) was not equivalent [41, [44] [45] [46] 50] , we note that none reported any cases of AAGA. It is therefore unlikely that inclusion of such studies would have added to this review.
The findings of the present review have wider implications for both the synthesis and study of rare outcomes and adverse events in systematic reviews and RCTs, respectively. The issues surrounding sparse data and reliability in reviews has been explored in a recently published editorial -the conclusions of which emphasise the need for methodological rigour and due caution in interpretation [21] . Regarding RCTs, which are resource intensive and logistically demanding, it is difficult to recruit sufficient participants to detect even a small incidence rate for awareness. Indeed, assuming an incidence of accidental awareness of 1 out of 500 patients receiving general anaesthesia and that nitrous oxide leads to a 50% increase in awareness, an RCT would need to have over 11,737 participants in each group to have 80% power to detect the increase at 5% significance level. This would increase to 23,511 participants in each group if the incidence was assumed to be 1 out of 1000. A recent RCT with almost 11,000 in each group investigating the use of BIS on AAGA was terminated due to futility, with no significant difference in incidence being detected between groups [8] . If such studies were to be done, it may be advisable to focus on higher-risk groups such as those undergoing caesarean section, cardiac surgery or receiving neuromuscular blocking drugs or total i.v. anaesthesia. However, it is not clear that the costs involved would be justified. Although, without such studies, it is unlikely that any future meta-analyses would be able to draw any implications for clinical practice.
Owing to their scale, observational studies have the potential to address this issue. Observational studies may be of a prospective design, whereby study data are produced after study parameters have been set, or a retrospective design, whereby data originate from past cases. In both, it is also important to acknowledge the possible biases introduced through self-reporting. As mentioned, the prospectively designed NAP5 study, which examined spontaneous reports of AAGA arising from approximately 3 million general anaesthetics, found no association between nitrous oxide use and AAGA [13, 14] . The lower overall incidence of reports of AAGA (1 out of 19,600) in NAP5 may reflect that ascertainment relied on spontaneous self-reports of AAGA, and it is unclear whether this design underestimated the incidence rate. The routine use of direct questioning in conjunction with routine data has the potential to provide further data. In the NAP5 study, obstetric surgery patients were identified as being at a potentially higher risk of AAGA than other patient groups. A future source of evidence addressing this particular group may come from the planned prospective observational study 'Direct REporting of Awareness in MaternitY patients (DREAMY)' [71] .
